최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Arthritis and rheumatism, v.60 no.4, 2009년, pp.1006 - 1019
González, Manuel A. (Cellerix SA, Tres Cantos, and Fundació) , Gonzalez-Rey, Elena (n Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain) , Rico, Laura (University of Seville, Seville, Spain) , Büscher, Dirk (Cellerix SA, Tres Cantos, Spain) , Delgado, Mario (Cellerix SA, Tres Cantos, Spain)
ObjectiveRheumatoid arthritis (RA) is a chronic autoimmune disease caused by loss of immunologic self tolerance and characterized by chronic joint inflammation. Adult mesenchymal stem cells (MSCs) were recently found to suppress effector T cell responses and to have beneficial effects in various imm...
Firestein, Gary S.. Evolving concepts of rheumatoid arthritis. Nature, vol.423, no.6937, 356-361.
Sakaguchi, Shimon, Yamaguchi, Tomoyuki, Nomura, Takashi, Ono, Masahiro. Regulatory T Cells and Immune Tolerance. Cell, vol.133, no.5, 775-787.
Morgan, Mary E., Flierman, Roelof, van Duivenvoorde, Leonie M., Witteveen, Hendrik J., van Ewijk, Willem, van Laar, Jacob M., de vries, René R. P., Toes, René E. M.. Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis and rheumatism, vol.52, no.7, 2212-2221.
van Amelsfort, Jocea M. R., Jacobs, Kim M. G., Bijlsma, Johannes W. J., Lafeber, Floris P. J. G., Taams, Leonie S.. CD4+CD25+ regulatory T cells in rheumatoid arthritis: Differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis and rheumatism, vol.50, no.9, 2775-2785.
10.1002/1529-0131(200003)43:3<617::AID-ANR19>3.0.CO;2-B
Morgan, Mary E., Sutmuller, Roger P. M., Witteveen, Hendrik J., van Duivenvoorde, Leonie M., Zanelli, Eric, Melief, Cornelis J. M., Snijders, Alies, Offringa, Rienk, de Vries, René R. P., Toes, René E. M.. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis and rheumatism, vol.48, no.5, 1452-1460.
Caplan, Arnold I.. Mesenchymal stem cells. Journal of orthopaedic research : official publication of the Orthopaedic Research Society, vol.9, no.5, 641-650.
Zuk, Patricia A., Zhu, Min, Mizuno, Hiroshi, Huang, Jerry, Futrell, J. William, Katz, Adam J., Benhaim, Prosper, Lorenz, H. Peter, Hedrick, Marc H.. Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies. Tissue engineering, vol.7, no.2, 211-228.
Rasmusson, Ida. Immune modulation by mesenchymal stem cells. Experimental cell research, vol.312, no.12, 2169-2179.
Nauta, Alma J., Fibbe, Willem E.. Immunomodulatory properties of mesenchymal stromal cells. Blood, vol.110, no.10, 3499-3506.
Bartholomew, Amelia, Sturgeon, Cord, Siatskas, Mandy, Ferrer, Karen, McIntosh, Kevin, Patil, Sheila, Hardy, Wayne, Devine, Steve, Ucker, David, Deans, Robert, Moseley, Annemarie, Hoffman, Ronald. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Experimental hematology, vol.30, no.1, 42-48.
Glennie, Sarah, Soeiro, Inês, Dyson, Peter J., Lam, Eric W.-F., Dazzi, Francesco. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood, vol.105, no.7, 2821-2827.
Beyth, Shaul, Borovsky, Zipora, Mevorach, Dror, Liebergall, Meir, Gazit, Zulma, Aslan, Hadi, Galun, Eithan, Rachmilewitz, Jacob. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood, vol.105, no.5, 2214-2219.
on behalf of the Developmental Committee of the European Group for Blood and Marrow Transplantation, Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M.E., Remberger, M., Dini, G., Egeler, R.M., Bacigalupo, A., Fibbe, W., Ringden, O.. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. The Lancet, vol.371, no.9624, 1579-1586.
Zappia, Emanuela, Casazza, Simona, Pedemonte, Enrico, Benvenuto, Federica, Bonanni, Ivan, Gerdoni, Ezio, Giunti, Debora, Ceravolo, Antonella, Cazzanti, Francesco, Frassoni, Francesco, Mancardi, Gianluigi, Uccelli, Antonio. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood, vol.106, no.5, 1755-1761.
Ohnishi, Shunsuke, Yanagawa, Bobby, Tanaka, Koichi, Miyahara, Yoshinori, Obata, Hiroaki, Kataoka, Masaharu, Kodama, Makoto, Ishibashi-Ueda, Hatsue, Kangawa, Kenji, Kitamura, Soichiro, Nagaya, Noritoshi. Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis. Journal of molecular and cellular cardiology, vol.42, no.1, 88-97.
Augello, Andrea, Tasso, Roberta, Negrini, Simone Maria, Cancedda, Ranieri, Pennesi, Giuseppina. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis and rheumatism, vol.56, no.4, 1175-1186.
Yañez, Rosa, Lamana, María Luisa, García‐Castro, Javier, Colmenero, Isabel, Ramírez, Manuel, Bueren, Juan A.. Adipose Tissue‐Derived Mesenchymal Stem Cells Have In Vivo Immunosuppressive Properties Applicable for the Control of the Graft‐Versus‐Host Disease. Stem cells®, vol.24, no.11, 2582-2591.
Liechty, Kenneth W., MacKenzie, Tippi C., Shaaban, Aimen F., Radu, Antoneta, Moseley, AnneMarie B., Deans, Robert, Marshak, Daniel R., Flake, Alan W.. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nature medicine, vol.6, no.11, 1282-1286.
Grinnemo, K.H, Månsson, A, Dellgren, G, Klingberg, D, Wardell, E, Drvota, V, Tammik, C, Holgersson, J, Ringdén, O, Sylvén, C, Le Blanc, K. Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium. The Journal of thoracic and cardiovascular surgery, vol.127, no.5, 1293-1300.
Zheng, Z H, Li, X Y, Ding, J, Jia, J F, Zhu, P. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.. Rheumatology, vol.47, no.1, 22-30.
Puissant, Bénédicte, Barreau, Corinne, Bourin, Philippe, Clavel, Cyril, Corre, Jill, Bousquet, Christine, Taureau, Christine, Cousin, Béatrice, Abbal, Michel, Laharrague, Patrick, Penicaud, Luc, Casteilla, Louis, Blancher, Antoine. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. British journal of haematology, vol.129, no.1, 118-129.
Cui, Lei, Yin, Shuo, Liu, Wei, Li, Ningli, Zhang, Wenjie, Cao, Yilin. Expanded Adipose-Derived Stem Cells Suppress Mixed Lymphocyte Reaction by Secretion of Prostaglandin E2. Tissue engineering, vol.13, no.6, 1185-1195.
Ann Rheum Dis Gonzalez‐Rey E 2009 Human adipose mesenchymal cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis
Delgado, Mario, Abad, Catalina, Martinez, Carmen, Leceta, Javier, Gomariz, Rosa P.. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nature medicine, vol.7, no.5, 563-568.
Kasama, T, Strieter, R M, Lukacs, N W, Lincoln, P M, Burdick, M D, Kunkel, S L. Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis.. The Journal of clinical investigation, vol.95, no.6, 2868-2876.
Haniffa, Muzlifah A., Wang, Xiao-Nong, Holtick, Udo, Rae, Michelle, Isaacs, John D., Dickinson, Anne M., Hilkens, Catharien M. U., Collin, Matthew P.. Adult Human Fibroblasts Are Potent Immunoregulatory Cells and Functionally Equivalent to Mesenchymal Stem Cells. The journal of immunology : official journal of the American Association of Immunologists, vol.179, no.3, 1595-1604.
J Immunol Seki N 1477 140 1988 10.4049/jimmunol.140.5.1477 Type II collagen‐induced murine arthritis induction and perpetuation of arthritis require synergy between humoral and cell‐mediated immunity
Wraith, David C, Nicolson, Kirsty S, Whitley, Nathaniel T. Regulatory CD4+ T cells and the control of autoimmune disease. Current opinion in immunology, vol.16, no.6, 695-701.
Walmsley, Marita, Katsikis, Peter D., Abney, Erika, Parry, Sarah, Williams, Richard O., Maini, Ravinder N., Feldmann, Marc. Interleukin‐10 inhibition of the progression of established collagen‐induced arthritis. Arthritis and rheumatism, vol.39, no.3, 495-503.
Groux, Hervé, O'Garra, Anne, Bigler, Mike, Rouleau, Matthieu, Antonenko, Svetlana, de Vries, Jan E., Roncarolo, Maria Grazia. A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature, vol.389, no.6652, 737-742.
Horwitz, David A., Zheng, Song Guo, Gray, J. Dixon. The role of the combination of IL‐2 and TGF‐β or IL‐10 in the generation and function of CD4 + CD25 + and CD8 + regulatory T cell subsets. Journal of leukocyte biology, vol.74, no.4, 471-478.
Li, Lequn, Godfrey, Wayne R., Porter, Stephen B., Ge, Ying, June, Carle H., Blazar, Bruce R., Boussiotis, Vassiliki A.. CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy. Blood, vol.106, no.9, 3068-3073.
Kreijveld, Ellen, Koenen, Hans J. P. M., Hilbrands, Luuk B., van Hooff, Hans J. P., Joosten, Irma. The immunosuppressive drug FK778 induces regulatory activity in stimulated human CD4+CD25− T cells. Blood, vol.109, no.1, 244-252.
Haematologica Maccario R 516 90 2005 Interaction of human mesenchymal stem cells with cells involved in alloantigen‐specific immune response favors the differentiation of CD4+ T‐cell subsets expressing a regulatory/suppressive phenotype
Li, Yin-Ping, Paczesny, Sophie, Lauret, Evelyne, Poirault, Sonia, Bordigoni, Pierre, Mekhloufi, Fatiha, Hequet, Olivier, Bertrand, Yves, Ou-Yang, Jing-Ping, Stoltz, Jean-François, Miossec, Pierre, Eljaafari, Assia. Human Mesenchymal Stem Cells License Adult CD34+ Hemopoietic Progenitor Cells to Differentiate into Regulatory Dendritic Cells through Activation of the Notch Pathway. The journal of immunology : official journal of the American Association of Immunologists, vol.180, no.3, 1598-1608.
Jiang, Xiao-Xia, Zhang, Yi, Liu, Bing, Zhang, Shuang-Xi, Wu, Ying, Yu, Xiao-Dan, Mao, Ning. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood, vol.105, no.10, 4120-4126.
Gastroenterology. Gonzalez MA 2008 Adipose‐derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses
Barry, Frank P., Murphy, J. Mary, English, Karen, Mahon, Bernard P.. Immunogenicity of Adult Mesenchymal Stem Cells: Lessons from the Fetal Allograft. Stem cells and development, vol.14, no.3, 252-265.
Aggarwal, Sudeepta, Pittenger, Mark F.. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, vol.105, no.4, 1815-1822.
Sato, Kazuya, Ozaki, Katsutoshi, Oh, Iekuni, Meguro, Akiko, Hatanaka, Keiko, Nagai, Tadashi, Muroi, Kazuo, Ozawa, Keiya. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood, vol.109, no.1, 228-234.
Hwa Cho, Hyun, Bae, Yong Chan, Jung, Jin Sup. Role of Toll‐Like Receptors on Human Adipose‐Derived Stromal Cells. Stem cells®, vol.24, no.12, 2744-2752.
Feldmann, Marc, Brennan, Fionula M., Maini, Ravinder N.. ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS. Annual review of immunology, vol.14, 397-440.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.